What can the International Space Station teach us about mudslides here on Earth? UC San Diego engineers are trying to better understand the role gravity plays in mudslides. That is why in 18 months, they will launch an experiment to the ISS via SpaceX and NASA to study mudslides in micro gravity.
A new kind of radar could make it possible for self-driving cars to navigate safely in bad weather. Electrical engineers at UC San Diego improved the imaging capability of existing radar sensors so that they accurately predict the dimensions of cars in live traffic, even in fog.
UC San Diego researchers have identified new mechanisms in neurons that cause Alzheimer’s disease. In particular, they discovered that structural changes in chromatin trigger neurons to lose their specialized function and revert to a precursor-like state.
A new process for restoring spent cathodes to mint condition could make it more economical to recycle lithium-ion batteries. The process consumes 80 to 90% less energy than today's methods, emits about 75% less greenhouse gases, and uses environmentally benign, inexpensive ingredients.
Finding just the right model to study human development—from the early embryonic stage onward—has been a challenge for scientists over the last decade. Now, bioengineers at the University of California San Diego have homed in on an unusual candidate: teratomas.
Researchers determined that COVID-19 transmission risk via Halloween candies is low, even when they are handled by infected people, but handwashing and disinfecting collected sweets reduces risk even further.
UC San Diego researchers use experimental artificial intelligence system called DrugCell to predict the best approach to treating cancer. Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
San Diego-based Cellics Therapeutics, which was co-founded by UC San Diego nanoengineering Professor Liangfang Zhang, has received an award of up to $15M to develop a macrophage cellular nanosponge—nanoparticles cloaked in the cell membranes of macrophages—designed to treat sepsis.
Treatment with a peptide that mimics the naturally occurring protein GIV prevents immune overreaction and supports a mechanism critical for survival in mouse models of sepsis and colitis, according to a UC San Diego study.
Diverse teams across University of California San Diego, with collaborators elsewhere, have received two 5-year grants totaling $14.3 million from the National Institutes of Health (NIH) Common Fund to continue their work as a 4D Nucleome Research Hub and Center.